Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-AGL Antibody (R1V11)

Catalog #:   RHE13001 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: FCM, IF, IHC, WB
Accession: P35573
Overview

Catalog No.

RHE13001

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

FCM: 1:20-1:100, IF: 1:50-1:200, IHC: 1:100-1:200, WB: 1:1000-1:2000

Target

Dextrin 6-alpha-D-glucosidase, GDE, Glycogen debranching enzyme, Amylo-1,6-glucosidase, AGL, Oligo-1,4-1,4-glucantransferase, Glycogen debrancher

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P35573

Applications

FCM, IF, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1V11

Data Image
  • Western blot
    Western blot analysis of AGL expression in K562 cell lysate.
  • Western blot
    All lanes use the Antibody at 1:1K dilution for 1 hour at room temperature.
  • Western blot
    All lanes use the Antibody at 1:1K dilution for 1 hour at room temperature.
References

A modular mRNA vaccine platform encoding antigen-presenting capsid virus-like particles enhances the immunogenicity of the malaria antigen Pfs25., PMID:40369344

Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis and Associated Retinal Ischemia., PMID:40229936

Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis., PMID:39993400

Efficacy of transitioning from alglucosidase alfa to avalglucosidase alfa in infantile-onset Pompe disease: A single-center cohort analysis., PMID:39927452

Pembrolizumab-induced acquired lipodystrophy: a case report and review of the literature., PMID:39704080

Antiphospholipid Antibody Syndrome: Concurrent Retinal Vein Occlusion and Homonymous Hemianopia From Ischemic Stroke., PMID:39690444

Patient Preferences with Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Multinational Discrete Choice Experiment Study., PMID:39571557

Optimizing resources: low-dose nivolumab combinations in the management of relapsed/refractory Hodgkin lymphoma., PMID:39562359

Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study., PMID:39053949

Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial., PMID:39043980

Scleritis as the Presenting Sign of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the Setting of Temporal Arteritis., PMID:38863111

Leber Hereditary Optic Neuropathy Plus Phenotype With Double Point Mutations (m.11778 G>A and m.14484T>C) and Concurrent Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease., PMID:38587899

Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies., PMID:38545781

Ganglioside (GM1) Immunoglobulin G Antibody Chronic Bilateral Ophthalmoplegia., PMID:38354054

Spontaneous Remission of Acquired Generalized Lipodystrophy Presenting in the Postpartum Period., PMID:38314238

Identification of patient endotypes and adalimumab treatment responders in axial spondyloarthritis using blood-derived extracellular matrix biomarkers., PMID:38199849

Paraneoplastic Autoimmune Retinopathy Associated With Non-IgM Lymphoplasmacytic Lymphoma., PMID:37974368

Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1)., PMID:37919141

KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema., PMID:37460036

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis Mimicking Pituitary Apoplexy With Bitemporal Field Loss., PMID:36542667

Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: clinical outcomes in real-world patients from the DANBIO registry., PMID:36418087

Absence of anti-Besnoitia spp. specific antibodies in European wild lagomorphs from the Iberian Peninsula., PMID:36215394

In vitro/in vivo degradation analysis of trastuzumab by combining specific capture on HER2 mimotope peptide modified material and LC-QTOF-MS., PMID:36038230

Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease., PMID:36031810

Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases., PMID:35869807

Characterization and Clinical Association of Autoantibodies Against Perilipin 1 in Patients With Acquired Generalized Lipodystrophy., PMID:35771980

Delayed Diagnosis of Anti-Myelin Oligodendrocyte Glycoprotein One Decade After Presumed Recurrent Acute Disseminated Encephalomyelitis., PMID:35594158

Anti-Asialo GM1 Antibody-Positive Optic Neuritis and Optic Perineuritis in Chronic Inflammatory Demyelinating Polyneuropathy., PMID:35234692

Confirmatory detection of neutralizing antibodies to AAV gene therapy using a cell-based transduction inhibition assay., PMID:35141351

Andrographolide: A Herbal-Chemosynthetic Approach for Enhancing Immunity, Combating Viral Infections, and Its Implication on Human Health., PMID:34834128

COVID-19: Using high-throughput flow cytometry to dissect clinical heterogeneity., PMID:34811890

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine., PMID:34587382

The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell Arteritis., PMID:34415267

Detection of Begomovirus in chilli and tomato plants using functionalized gold nanoparticles., PMID:34244585

Effects of subcutaneous injection of λ/κ-carrageenin on the immune and liver antioxidant status of gilthead seabream (Sparus aurata)., PMID:34032302

Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trial., PMID:33926921

SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study., PMID:33865504

Paraneoplastic Cone Dysfunction Secondary to Renal Cell Carcinoma: A Case Report., PMID:33840753

Postinfectious Optic Neuritis After Hand-Foot-Mouth Disease., PMID:33417416

Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration., PMID:32950963

Survival patterns of childhood neuroblastoma: an analysis of clinical data from Southern-Eastern European countries., PMID:32925511

Development and validation of a novel immunogenicity assay to detect anti-drug and anti-PEG antibodies simultaneously with high sensitivity., PMID:32916164

A Case of Miller Fisher Syndrome Due to the Use of Cemiplimab., PMID:32868575

A protective bivalent vaccine against Rift Valley fever and bluetongue., PMID:32793399

Immunoreactivity pattern of monoclonal antibodies against Hepatitis B vaccine with global Hepatitis B virus genotypes., PMID:32679130

Recent Advances in Manufacturing Innovative Stents., PMID:32294908

Vascular wall injury and inflammation are key pathogenic mechanisms responsible for early testicular degeneration during acute besnoitiosis in bulls., PMID:32122380

Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries., PMID:32111583

MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses., PMID:32059491

Detection of DDT and carbaryl pesticides in honey by means of immunosensors based on high fundamental frequency quartz crystal microbalance (HFF-QCM)., PMID:31965575

Datasheet

Document Download

Anti-AGL Antibody (R1V11).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-AGL Antibody (R1V11) [RHE13001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only